Invention Grant
- Patent Title: Treatment of respiratory disorders using ROR-gamma inhibitors
-
Application No.: US15169325Application Date: 2016-05-31
-
Publication No.: US09855229B2Publication Date: 2018-01-02
- Inventor: Neelima Khairatkar-Joshi , Abhay Kulkarni , Daisy Manish Shah , Vikram Mansingh Bhosale , Bhavik Jaysukhlal Lodhiya , Alamelu Mangai Thiraviam , Megha Marathe , Avinash Annaso Hadambar
- Applicant: Glenmark Pharmaceuticals S.A.
- Applicant Address: CH La Chaux-de-Fonds
- Assignee: GLENMARK PHARMACEUTICALS S.A.
- Current Assignee: GLENMARK PHARMACEUTICALS S.A.
- Current Assignee Address: CH La Chaux-de-Fonds
- Agency: Blank Rome LLP
- Priority: IN2091/MUM/2015 20150529; IN201621011426 20160331
- Main IPC: A61K31/167
- IPC: A61K31/167 ; A61K31/437 ; A61K31/4184 ; A61K31/351 ; A61K31/44 ; A61K31/404 ; A61K9/00 ; G01N33/50 ; A61K31/35
Abstract:
The present patent application relates to treatment of a respiratory disorder using retinoid-related orphan receptor gamma t (ROR-gamma) modulators. Particularly, the present patent application relates to treatment of a respiratory disorder using a RORγ inhibitor, wherein the RORγ inhibitor is administered by an inhalation route to a subject in need thereof.
Public/Granted literature
- US20160346234A1 TREATMENT OF RESPIRATORY DISORDERS USING ROR-GAMMA INHIBITORS Public/Granted day:2016-12-01
Information query
